CClinicalTrials.gg
Not yet recruitingNCT06103305Updated Jul 30, 2024

Risk Stratifications for Patients With Palpitations

An observational study in Arrhythmias, Cardiac, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-30.

Sponsored by Assiut University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
208
Ages
18 Years to 80 Years
Sex
All
01

Study summary

the aim of the study is to early diagnose and early proper mangment of those patients who have palpitations specially of cardiac origin

Read the detailed description

Palpitation : are one of the most common presentations to general practice, and while they are usually benign, they may also have life-threatening significance. Palpitations have been estimated to account for 16% of general practice presentations and are the second most common presentation to cardiologists after chest pain.

02

Conditions studied

  • Arrhythmias, Cardiac

Browse trials for

Keywords

  • palpitations
03

In context

Arrhythmias, Cardiac

885 studies on the registry are indexed under Arrhythmias, Cardiac; 235 are open to participants now.

This study's planned enrollment of 208 is close to the median of 200 across 414 observational studies indexed under Arrhythmias, Cardiac.

Browse Arrhythmias, Cardiac studies →

Lead sponsor

Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

patients from 18 years old to 80 years old come to emergency department with palpitations

Inclusion criteria

The present study will be conducted on patients with Palpitations "without intently selected certain gender" and had 18 years old or more

Exclusion criteria

Exclusion Criteria:

patients refusing study will be excluded.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
208 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Mortality

    Mortality during 30 days follow up

    Time frame: 30 days

Secondary outcomes

  1. Hospital admission

    Admission to hospital from the Emergency Department

    Time frame: 0 days

  2. ICU admission

    Admission to the Intensive Care Unit or High Dependency Unit from the Emergency Department

    Time frame: 0 days

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Giada F, Inama G, Bertaglia M, Pedrinazzi C, Gulizia M, Ricci R, Raviele A; Associazione Italiana di Aritmologia e Cardiostimolazione. [Management of patients with palpitations. Consensus document of the AIAC (Italian Association of Arrhythmiology and Cardiostimulation]. G Ital Cardiol (Rome). 2010 Apr;11(4):329-40. No abstract available. Italian. PubMed 20677582 ↗
  • Probst MA, Mower WR, Kanzaria HK, Hoffman JR, Buch EF, Sun BC. Analysis of emergency department visits for palpitations (from the National Hospital Ambulatory Medical Care Survey). Am J Cardiol. 2014 May 15;113(10):1685-90. doi: 10.1016/j.amjcard.2014.02.020. Epub 2014 Mar 1. PubMed 24698469 ↗
  • Weber BE, Kapoor WN. Evaluation and outcomes of patients with palpitations. Am J Med. 1996 Feb;100(2):138-48. doi: 10.1016/s0002-9343(97)89451-x. Erratum In: Am J Med 1997 Jul;103(1):86. PubMed 8629647 ↗
  • Lessmeier TJ, Gamperling D, Johnson-Liddon V, Fromm BS, Steinman RT, Meissner MD, Lehmann MH. Unrecognized paroxysmal supraventricular tachycardia. Potential for misdiagnosis as panic disorder. Arch Intern Med. 1997 Mar 10;157(5):537-43. PubMed 9066458 ↗
  • Porter MJ, Morton JB, Denman R, Lin AC, Tierney S, Santucci PA, Cai JJ, Madsen N, Wilber DJ. Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm. 2004 Oct;1(4):393-6. doi: 10.1016/j.hrthm.2004.05.007. PubMed 15851189 ↗
  • Gale CP, Camm AJ. Assessment of palpitations. BMJ. 2016 Jan 6;352:h5649. doi: 10.1136/bmj.h5649. No abstract available. PubMed 26739319 ↗
  • Dixit S, Stein PK, Dewland TA, Dukes JW, Vittinghoff E, Heckbert SR, Marcus GM. Consumption of Caffeinated Products and Cardiac Ectopy. J Am Heart Assoc. 2016 Jan 26;5(1):e002503. doi: 10.1161/JAHA.115.002503. PubMed 26813889 ↗
  • Ng GA. Treating patients with ventricular ectopic beats. Heart. 2006 Nov;92(11):1707-12. doi: 10.1136/hrt.2005.067843. No abstract available. PubMed 17041126 ↗
  • Reddy RK, Pooni R, Zaharieva DP, Senf B, El Youssef J, Dassau E, Doyle Iii FJ, Clements MA, Rickels MR, Patton SR, Castle JR, Riddell MC, Jacobs PG. Accuracy of Wrist-Worn Activity Monitors During Common Daily Physical Activities and Types of Structured Exercise: Evaluation Study. JMIR Mhealth Uhealth. 2018 Dec 10;6(12):e10338. doi: 10.2196/10338. PubMed 30530451 ↗
  • Raviele A, Giada F, Bergfeldt L, Blanc JJ, Blomstrom-Lundqvist C, Mont L, Morgan JM, Raatikainen MJ, Steinbeck G, Viskin S, Kirchhof P, Braunschweig F, Borggrefe M, Hocini M, Della Bella P, Shah DC; European Heart Rhythm Association. Management of patients with palpitations: a position paper from the European Heart Rhythm Association. Europace. 2011 Jul;13(7):920-34. doi: 10.1093/europace/eur130. No abstract available. PubMed 21697315 ↗
  • Thavendiranathan P, Bagai A, Khoo C, Dorian P, Choudhry NK. Does this patient with palpitations have a cardiac arrhythmia? JAMA. 2009 Nov 18;302(19):2135-43. doi: 10.1001/jama.2009.1673. PubMed 19920238 ↗
  • Voskoboinik A, Prabhu S, Ling LH, Kalman JM, Kistler PM. Alcohol and Atrial Fibrillation: A Sobering Review. J Am Coll Cardiol. 2016 Dec 13;68(23):2567-2576. doi: 10.1016/j.jacc.2016.08.074. PubMed 27931615 ↗
  • Flannery MD, Kalman JM, Sanders P, La Gerche A. State of the Art Review: Atrial Fibrillation in Athletes. Heart Lung Circ. 2017 Sep;26(9):983-989. doi: 10.1016/j.hlc.2017.05.132. Epub 2017 Jun 3. PubMed 28606607 ↗
  • Flaker GC, Belew K, Beckman K, Vidaillet H, Kron J, Safford R, Mickel M, Barrell P; AFFIRM Investigators. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2005 Apr;149(4):657-63. doi: 10.1016/j.ahj.2004.06.032. PubMed 15990749 ↗
  • Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW Jr, Stevenson WG, Tomaselli GF, Antman EM, Smith SC Jr, Alpert JS, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Hiratzka LF, Hunt SA, Jacobs AK, Russell RO Jr, Priori SG, Blanc JJ, Budaj A, Burgos EF, Cowie M, Deckers JW, Garcia MA, Klein WW, Lekakis J, Lindahl B, Mazzotta G, Morais JC, Oto A, Smiseth O, Trappe HJ; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines. Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Circulation. 2003 Oct 14;108(15):1871-909. doi: 10.1161/01.CIR.0000091380.04100.84. No abstract available. PubMed 14557344 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 30, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06103305
Lead sponsor
Assiut University
Responsible party
Mina Zakaria Farah Tawdros (Resident physician, Assiut University) — Principal investigator
First posted
Oct 26, 2023
Start date
Oct 2024 (estimated)
Primary completion
Aug 2026 (estimated)
Completion
Sep 2026 (estimated)
Last update
Jul 30, 2024

Study contacts

Mina Farah tawdros, Master
Contact
zakariamena3@gmail.com
+201208727713
Ragaa Ahmed Herdan, professor
study director · Assiut University
Monira Taha ismail, professor
study director · Suez Canal University
Hany El moraba, professor
study director · Assiut University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion